Company Analysis
Sign in

Absci Corporation (ABSI)

Nasdaq: ABSI · Services-Commercial Physical & Biological Research · Vancouver, WA · filing with the SEC since 2016
Full chart Alerts Compare
Grade3.9
◀ Past 3.8● Present 4.1▶ Future 3.8
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Report filedMar 24, 2026Mar 18, 2025Mar 21, 2024Mar 30, 2023Mar 22, 2022·
Revenue2,8004,5345,7184,5294,0094,117
Research and development81,41863,85948,06758,90844,58611,448
Selling, general and administrative35,05836,17437,83240,55228,7805,502
Total operating expenses123,117113,422121,233112,49780,02018,081
Operating income-120,317-108,888-115,515-106,750-75,238-13,301
Interest expense2095651,0109723,432634
Other income (expense), net5,4126,4176,0592,357-31,189-418
Total non-operating income (expense)5,2035,8525,0491,385-34,621-1,052
Income before income taxes-115,114-103,036-110,466-105,365-109,859-14,353
Income tax expense6970100-461-8,8990
Net income-115,183-103,106-110,566-104,904-100,960-14,353
Net income to common shareholders··-110,566-104,904-103,244-49,469
Earnings per share, basic-0.84-0.94-1.20-1.15-2.08-3.19
Earnings per share, diluted-0.84-0.94-1.20-1.15-2.08-3.19
Weighted average shares, basic136,776,885110,239,87092,028,01690,845,62949,685,19415,494,908
Weighted average shares, diluted136,776,885110,239,87092,028,01690,845,62949,685,19415,494,908
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:Revenues
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton ABSI · research, not advice